LincRNA‐regulator of reprogramming (Linc‐RoR), a regulator that promotes oestrogen‐independent breast cancer cell growth and tamoxifen resistance, plays an essential role in endocrine therapy resistance of breast cancer. Here, LINC-ROR is linked to breast cancer.